Year All20242023202220212020201920182017201620152014 Abivax KOL event today in Paris on ABX464 therapeutic-candidate in mid-stage clinical testing for ulcerative colitis and HIV November 09, 2018 Read More Abivax First-Half 2018 Financial Results and Operations Update September 28, 2018 Read More Abivax reports impressive results in clinical phase 2a trial of ABX464 as an oral treatment for ulcerative colitis patients September 04, 2018 Read More Abivax Presents ABX464 Mechanism of Action Data at the 22nd International AIDS Conference (AIDS 2018) July 26, 2018 Read More ABIVAX secures up to EUR 20m Debt Financing from Kreos Capital July 25, 2018 Read More Abivax Sponsors Prize for HIV Cure Projects July 24, 2018 Read More Abivax Completes Dosing in Phase 2a Proof-of-Concept Clinical Trial of ABX464 in Ulcerative Colitis (ABX464-101) July 19, 2018 Read More Abivax releases positive top line data from ABX464-005 phase 2a study in HIV infection July 03, 2018 Read More Abivax Appoints Ian McGowan as Scientific Advisory Board Chair and Juergen Rockstroh as a New Member June 25, 2018 Read More ABIVAX Presents New Data on ABX464 Mechanism of Action at 16th European Meeting on HIV & Hepatitis May 31, 2018 Read More
Abivax KOL event today in Paris on ABX464 therapeutic-candidate in mid-stage clinical testing for ulcerative colitis and HIV November 09, 2018 Read More
Abivax reports impressive results in clinical phase 2a trial of ABX464 as an oral treatment for ulcerative colitis patients September 04, 2018 Read More
Abivax Presents ABX464 Mechanism of Action Data at the 22nd International AIDS Conference (AIDS 2018) July 26, 2018 Read More
Abivax Completes Dosing in Phase 2a Proof-of-Concept Clinical Trial of ABX464 in Ulcerative Colitis (ABX464-101) July 19, 2018 Read More
Abivax releases positive top line data from ABX464-005 phase 2a study in HIV infection July 03, 2018 Read More
Abivax Appoints Ian McGowan as Scientific Advisory Board Chair and Juergen Rockstroh as a New Member June 25, 2018 Read More
ABIVAX Presents New Data on ABX464 Mechanism of Action at 16th European Meeting on HIV & Hepatitis May 31, 2018 Read More
